#IDSky#ClinMicro
LightNews LightNews
cmicomms.bsky.social
🎙️ Just published: Communicable E42...

Hosted by @angelahuttner.bsky.social & @marcbonten.bsky.social

w/ invited guests Ilan Schwartz @germhuntermd.bsky.social, Neil Stone @drneilstone.bsky.social & Tara Smith @aetiology.bsky.social

Listen on #Communicable:

#IDSky #Clinmicro #IDTwitter
Communicable E42: Should doctors stay at X (Twitter) or leave it?
During the COVID-19 pandemic with lockdown mandates and social...
share.transistor.fm
December 14, 2025 at 11:00 PM
cmicomms.bsky.social
📣 New #Communicable drops Mon 15 Dec!
@angelahuttner.bsky.social & @marcbonten.bsky.social invite Ilan Schwartz @germhuntermd.bsky.social , Neil Stone @drneilstone.bsky.social & Tara Smith @aetiology.bsky.social to debate staying on or leaving Twitter for alternatives 🎤

#IDTwitter #IDSky #clinmicro
December 11, 2025 at 8:34 AM
cmicomms.bsky.social
📣 Systematic review on ESBL+ #Enterobacterales in HIC community dwellers over time:

Median prevalence in 2002 was 3% but now is 19%
8-37% of family members become #ESBL carriers
Few data on interventions to prevent community transmission

#IDSky #clinmicro #MedSky
www.cmi-comms.org/article/S295...
Community human-to-human transmission of multidrug-resistant Enterobacterales in high-income countries: A systematic review
Multidrug-resistant Enterobacterales (MDRE) are widespread globally, representing a major health burden [1–3]. In recent years, faecal carriage of MDRE, namely extended-spectrum β-lactamase producing ...
www.cmi-comms.org
December 10, 2025 at 6:26 AM
evaheinz7.bsky.social
New editor's spotlights to highlight some of the exciting work we see at #MGen, getting kicked off by @bjesseshapiro.bsky.social diving into the latest work from @sylvainbrisse.bsky.social et al 🔍 vaccine impacts on non-target species!
#MicroSky #MicrobiomeSky #IDSky #MedSky #evobio #clinmicro 💻🧬 🧪
microbiologysociety.org Microbiology Society @microbiologysociety.org · 15d
📣🦠Check out our new Editor’s Spotlight! Senior MGEN editor Jesse Shapiro tells us about a recently published paper on the bystander effect on the evolution of Bordetella parapertussis, a non-target species of the pertussis vaccine #MGEN

Read the full blog here: microb.io/48zfOlJ
December 3, 2025 at 6:25 AM
escmid.bsky.social
☝️ESCMID's Emerging Infections Subcommittee publishes a special report on the Marburg virus outbreak in Ethiopia in November, and elaborate on the virus' epidemiological shift in East Africa.
https://ow.ly/fXvn50XAwwm

#IDSky #clinmicro
December 2, 2025 at 5:15 PM
escmid.bsky.social
🌱 Tomorrow, the ESCMID Sustainability Commission & ESGVM have organised 'Lab Sustainability: From Bench to Bedside to Planet' where you can learn more about 'going green' in your research environment 🌍

🗓️ Thurs, 4 Dec, 13:00 CET
🚀 Register now: https://ow.ly/V9ZI50XvLjn

#IDSky #clinmicro
December 3, 2025 at 12:00 PM
escmid.bsky.social
💡Nicholas Day has researched neglected tropical diseases for >30 years. In his keynote at #ESCMIDGlobal 2026, he focuses on rickettsioses: their widespread prevalence, global health burden & the most urgent needs to improve patient outcomes.

More info: https://ow.ly/Gg4f50XyZwL

#IDSky #clinmicro
December 2, 2025 at 10:40 AM
cmicomms.bsky.social
📣 We're thrilled to be part of #CLARITY, an initiative led by Josh Davis @gurujosh.bsky.social & @steventong.bsky.social for physicians, pharmacists & #clinmicro specialists passionate about #clinicalresearch & #evidence appraisal.
Join us! 🌱

#IDSky #MedSky #MedEd

www.cmi-comms.org/article/S295...
The CLARITY initiative: Clinical Literature Appraisal and Research education in InfecTious diseases and microbiologY
Over the past two decades, the generation and application of clinical evidence in the fields of clinical infectious diseases and microbiology have entered a new era: one in which clinical guidelines a...
www.cmi-comms.org
December 1, 2025 at 7:20 AM
escmid.bsky.social
📣Joint ESCMID/IDSA webinar TOMORROW! Join us as Dr. Arturo Casadevall & Dr. Cyril Caminade explore 2 key areas of concern: the rise of climate-driven fungal pathogens & the reach of vector-borne diseases. Register: https://ow.ly/h9KQ50XvJZH

🗓️ 2 Dec, 16:00 CET / 10:00 AM US EST

#IDSky #clinmicro
December 1, 2025 at 3:01 PM
cmicomms.bsky.social
Thanks to the authors @kevinsblake.bsky.social, to our peer reviewers, and to @gardp.bsky.social for this important collaboration!
#IDSky #clinmicro #MedSky #AMR
December 1, 2025 at 12:42 PM
cmicomms.bsky.social
🎙️ Just published: Communicable E41: Diagnostic s...

Hosted by Angela Huttner @angelahuttner.bsky.social & Annie Joseph @anniejoseph.bsky.social

w/ invited guests Daniel Morgan (USA) & Valerie Vaughn @valerievaughnmd.bsky.social

Listen on #Communicable:

#IDSky #Clinmicro #MedSky #meded
Communicable E41: Diagnostic stewardship
In the last ten years, 'diagnostic stewardship' has emerged as a core...
share.transistor.fm
November 30, 2025 at 11:00 PM
lancetmicrobe.bsky.social
Our latest editorial is now online in advance of our upcoming December issue

Neglected tropical diseases: golden age of elimination?

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #NTD #OpenAccess #OA
November 29, 2025 at 6:10 PM
lancetmicrobe.bsky.social
New research article

#HIV drug resistance during #antiretroviral therapy scale-up in Uganda, 2012–19: a population-based, longitudinal study

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #ViroSky #AMR #OpenAccess #OA
November 28, 2025 at 9:49 AM
escmid.bsky.social
🌱 The ESCMID Sustainability Commission & ESGVM have organised 'Lab Sustainability: From Bench to Bedside to Planet' where you can learn more about 'going green' in your research environment!

🗓️ Thurs, 04 Dec @ 13:00 CET
🚀 Register here: https://ow.ly/BLsg50XvLem

#IDSky #clinmicro
November 27, 2025 at 12:00 PM
escmid.bsky.social
📣The draft document "ESCMID clinical guidelines on the evaluation and management of a reported antibiotic allergy" is now available for public consultation. ESCMID members are invited to comment on the manuscript before 26 November 2025. https://ow.ly/cbNz50XlAVg

#IDSky #clinmicro
November 20, 2025 at 9:05 AM
cmicomms.bsky.social
🌱 New opportunity: We are recruiting a new associate editor for our journal with expertise in viral infections & antiviral therapy. Read our call and apply if you're a good fit! www.cmi-comms.org/article/S295...

⏰ Deadline: 15 Dec 2025

#IDSky #clinmicro #virology #virosky
An open call to join the CMI Communications editorial team: editor in viral infections and antiviral therapy
CMI Communications, the official open-access journal of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), is looking for an editor with strong clinical and research exper...
www.cmi-comms.org
November 18, 2025 at 3:38 PM
cmicomms.bsky.social
🎙️ Just published: Communicable E40: AMR in conflict and crisis zones

Hosted by Nav Narayanan & Thomas Tängdén

w/ invited guests Aula Abbara (UK), Guido Granata (Italy), Tuomas Aro (Finland)

Listen on #Communicable:

#IDSky #Clinmicro #WAAW2025 #AMR @taescmid.bsky.social
Communicable E40: AMR in conflict and crisis zones
It’s World AMR Awareness Week (WAAW) and we have prepared a special...
share.transistor.fm
November 16, 2025 at 11:00 PM
escmid.bsky.social
Following the success of ESCMID's WAAW webinars, parts 1-3, "Rethinking the AMR response" series continues with the fourth and last part, next Tuesday (18 Nov) focusing on vaccines and AMR. Register: https://ow.ly/mJI550XojQ5

More info: https://ow.ly/hoH550XjxMz

#IDSky #clinmicro #AMR
November 13, 2025 at 3:40 PM
escmid.bsky.social
🚨 New Epi Alert this week: The Americas lost measles-free status, 95% in Canada, Mexico, US; Rift Valley Fever reached Gambia; worst ever outbreak of cholera in Sudan; Crimean-Congo Hemorrhagic fever in France among ticks and animals... More: https://ow.ly/t5S350XpQJT

#IDSky #clinmicro
November 12, 2025 at 6:30 AM
cmicomms.bsky.social
📣 In a US cohort of >2500 #bacteremia patients, #Serratia marcescens was associated with persistent bacteremia and cardiac devices. Yet WGS showed genetic diversity of isolates: infections are not clonal.

#IDSky #clinmicro #MedSky @vancefowler.bsky.social

www.cmi-comms.org/article/S295...
Clinical and genomic characterization of Serratia bloodstream infections
Previously considered a rare opportunistic pathogen, Serratia is now an emerging cause of bacteraemia. We compared the risk factors and outcomes of patients with Serratia bacteraemia relative to other...
www.cmi-comms.org
November 10, 2025 at 12:53 PM
cmicomms.bsky.social
📣 NEW: Tara Smith @aetiology.bsky.social replies to our recently published commentary on staying vs leaving Twitter 'Joining the X-odus'

Smith points out "the social cost of harassment and threats on Twitter/X, particularly for women" and more

www.cmi-comms.org/article/S295...

#IDSky #clinmicro
Twitter remains a haven of harassment
I am submitting a LTE regarding a recent CMI publication,
www.cmi-comms.org
November 4, 2025 at 12:45 PM
escmid.bsky.social
📣The draft document "ESCMID clinical guidelines on the evaluation and management of a reported antibiotic allergy" is now available for public consultation. ESCMID members are invited to comment on the manuscript before 26 November 2025. https://ow.ly/cbNz50XlAVg

#IDSky #clinmicro
November 4, 2025 at 9:05 AM
cmicomms.bsky.social
Better: ☺️

🎙️ Just published: Communicable E39: Dengue on the rise

Hosted by @anniejoseph.bsky.social & Nav Narayanan

w/ invited guests Steven Lim & Andre Siqueira @andre-siqueira.bsky.social

Listen on #Communicable:

#IDSky #Clinmicro #MedSky #dengue #virology

share.transistor.fm/s/48ae30ae
Communicable E39: Dengue on the rise | Communicable | Episode 39
Once confined to the tropics, dengue is spreading via its vector, the Aedes mosquito, to more temperate regions, causing increases in global morbidity, mortality and cost. In 2019, the WHO recognised ...
share.transistor.fm
November 3, 2025 at 5:16 AM
escmid.bsky.social
ESCMID's WAAW webinar series continues! Following the success of part 1, "Beyond the frontlines" series continues with part 2 next Tuesday (04 Nov) focusing on digital tools and AI in remote areas. Register: https://ow.ly/9PA250XjxMG

More info: https://ow.ly/hoH550XjxMz

#IDSky #clinmicro #AMR
October 31, 2025 at 8:10 AM
gpollara.bsky.social
Can't say I've even ever heard of cefdinir, probably cos we can't get it. But maybe we don't want it anyway! 😉 👇 #IDSky #ClinMicro #UTISky
lisaidpharmd.bsky.social Lisa Dumkow, PharmD, BCIDP, FIDP @lisaidpharmd.bsky.social · Oct 24
‼️Just shared at #IDWeek2025 & now published in @ofidjournal.bsky.social cephalexin vs. cefdinir for tx of uUTI in females. Spoiler: Cefdinir was independently associated with/failure & cefdinir pts were twice as likely to fail. Let’s stop Rx’ing cefdinir for UTI! 🛑💊 academic.oup.com/ofid/article...
Cefdinir Versus Cephalexin for the Treatment of Uncomplicated Urinary Tract Infections
Due to its poor bioavailability and urinary excretion, cefdinir may be a suboptimal agent for UTI treatment. Our findings demonstrate that patients treated
academic.oup.com
October 25, 2025 at 11:54 PM